Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$43.74 - $62.76 $441,774 - $633,876
10,100 Added 129.49%
17,900 $1.12 Million
Q4 2021

Feb 15, 2022

BUY
$50.01 - $73.35 $40,008 - $58,679
800 Added 11.43%
7,800 $437,000
Q3 2021

Nov 16, 2021

SELL
$59.21 - $78.66 $325,655 - $432,630
-5,500 Reduced 44.0%
7,000 $456,000
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $128,475 - $167,250
2,500 Added 25.0%
12,500 $793,000
Q1 2021

May 18, 2021

SELL
$49.14 - $59.89 $4,914 - $5,989
-100 Reduced 0.99%
10,000 $599,000
Q4 2020

Feb 17, 2021

BUY
$42.19 - $51.5 $189,855 - $231,750
4,500 Added 80.36%
10,100 $504,000
Q3 2020

Nov 17, 2020

BUY
$35.33 - $51.04 $197,848 - $285,824
5,600 New
5,600 $286,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.46B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.